#LCSM Chat Topic 3/9: Test Tumors to Target Lung Cancer

Our topic for the next #LCSM Chat on Thursday, March 9th at 5 PM Pacific (8 PM Eastern) is “Test Tumors to Target Lung Cancer.” Lung cancer treatments are evolving rapidly. Some newer treatments require testing to identify patients who are likely to respond to the drugs. The testing looks for certain biomarkers on the patient’s cancer tumors, like alterations in the tumor cells’ genes.  Patients whose tumors test positive may be able to take approved targeted therapy drugs that are usually more effective and more tolerable than chemo. A substantial percentage… Read More

#LCSM Chat Topic 8/25:  Pain and Lung Cancer Treatment: How Does it Affect You or Someone You Know?

Our topic for the next #LCSM Tweet Chat on Thursday, August 25th at 5 PM Pacific (8 PM Eastern) is “Pain and lung cancer treatment: How does it affect you or someone you know?”  The moderator for this chat is Dr. David Tom Cooke (@DavidCookeMD) Advances in the care and treatment of individuals with lung cancer are appearing rapidly.  With lung cancer screening we are finding earlier stage tumors.  With immunotherapy and targeted therapy, we are finding effective treatments for patients with advanced and metastatic lung cancer.  But during lung cancer interventions… Read More

#LCSM Chat Topic for 12/17: Reflecting on 2015, Projecting 2016 for the Lung Cancer Community

Some years are bigger than others, and by just about any measure, 2015 was a banner year for the lung cancer community. We saw new drug approvals for a wide range of lung cancer patients, including immunotherapy for patients with both squamous and non-squamous advanced NSCLC, as well as very recent approvals as holiday presents for patients with an EGFR mutation or ALK rearrangement. We saw many important trials in lung cancer become high priorities, a growing use of next generation sequencing to identify new targets, and new data and greater acceptance… Read More